SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-104145
Filing Date
2010-11-12
Accepted
2010-11-12 06:02:29
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q c08259e10vq.htm 10-Q 261286
2 EXHIBIT 31.1 c08259exv31w1.htm EX-31.1 9360
3 EXHIBIT 31.2 c08259exv31w2.htm EX-31.2 9351
4 EXHIBIT 32.1 c08259exv32w1.htm EX-32.1 4043
5 EXHIBIT 32.2 c08259exv32w2.htm EX-32.2 4122
  Complete submission text file 0000950123-10-104145.txt   289707
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 101181979
SIC: 2834 Pharmaceutical Preparations